AstraZeneca stock sits at EUR 142.63 with USD 248.3 billion market cap

Published on 10/08/2026 at 15:34 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Jefferies set GBp 17,500 on October 7, 2026. AstraZeneca stock costs EUR 142.63 on October 8, 2026 versus EUR 143.03.

Flatlay mit Aktienzertifikat, ISIN-Karte, Stethoskop und Impfstofffläschchen — AstraZeneca plc (ISIN GB0009895292) ist als forschendes Pharmaunternehmen an internationalen Börsen wie London gelistet, Illustration mit AI erstellt.

AstraZeneca stock (ISIN GB0009895292) was trading at EUR 142.63 at Lang & Schwarz on October 8, 2026 at 3:04 p.m. CEST, down 0.28 percent versus the EUR 143.03 prior close. Its market capitalization was USD 248.3 billion in the October 7, 2026 finance quote snapshot. The session places the stock below its previous Lang & Schwarz reference while keeping valuation and peer comparisons in view.

Bid and ask frame trading

The Lang & Schwarz bid stood at EUR 142.50 and the ask at EUR 142.75 at 3:04 p.m. CEST on October 8, 2026. The narrow EUR 0.25 spread gives the current quotation a defined intraday trading frame, while the daily move remains below the 1.00 percent threshold used for directional headline language.

Range and valuation levels

The primary-market finance snapshot dated October 7, 2026 placed AstraZeneca's 52-week range at USD 153.41 to USD 212.71. That range is stated in US dollars and is therefore kept separate from the euro quotation at Lang & Schwarz.

The same snapshot showed a P/E ratio of 23.90, a trailing dividend yield of 2.00 percent and a market capitalization of USD 248.3 billion. These figures describe the valuation frame, not a trading recommendation. The finance profile classifies AstraZeneca as Healthcare and Drug Manufacturers - General.

Comparison with peers

The finance quote snapshot dated October 7, 2026 reports the following three-line comparison:
AstraZeneca: plus 0.95 percent, P/E 23.90, USD 248.3 billion market capitalization
GSK: plus 0.90 percent, P/E 14.81, USD 94.2 billion market capitalization
Novartis: plus 1.77 percent, P/E 21.82, USD 272.3 billion market capitalization

Targets and the next date

Yahoo Finance reported on October 7, 2026 that Jefferies maintained a Buy rating and a GBp 17,500 price target. The report also identified AstraZeneca's listings as LSE:AZN and NASDAQ:AZN, with the LSE serving as the primary exchange for the ordinary share identified by ISIN GB0009895292.

The next earnings date is listed as October 30, 2026, for third-quarter 2026 results by Nemo. The date gives the calendar a concrete reference point for the next reported operating update.

Stock quote remains the anchor

The euro reference remains EUR 142.63 at Lang & Schwarz on October 8, 2026 at 3:04 p.m. CEST, with a minus 0.28 percent change against the EUR 143.03 prior close. The further course of trading is shown by the continuously updated real-time quote of AstraZeneca stock.